Peter Laverman

6.4k citations

123 papers · 5.2k indexed · h-index 41

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Biomaterials top 1%
- Nanoparticle-Based Drug Delivery

Papers in

Radiology, Nuclear Medicine and Imaging 67
- Radiopharmaceutical Chemistry and Applications 48
- Medical Imaging Techniques and Applications 24
- Monoclonal and Polyclonal Antibodies Research 14
Oncology 40
- Peptidase Inhibition and Analysis 27

Co-authors: Otto C. Boerman Wim J.G. Oyen Frans H.M. Corstens Gert Storm E.T.M. Dams David M. Goldenberg William J. McBride Robert M. Sharkey
Journals: European Journal of Nuclear Medicine and Molecular Imaging (15 papers)Journal of Nuclear Medicine (11 papers)Bioconjugate Chemistry (6 papers)Nuclear Medicine and Biology (6 papers)Molecular Imaging and Biology (4 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Peter Laverman

123 papers receiving 5.1k citations

Peers

Countries citing papers authored by Peter Laverman

Since Specialization

Citations

This map shows the geographic impact of Peter Laverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Laverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Laverman more than expected).

Fields of papers citing papers by Peter Laverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Laverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Laverman. The network helps show where Peter Laverman may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Laverman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Laverman Line = papers co-authored together Peter Laverman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis Arthritis Research & Therapy ·A. Veloza, Irene Di Ceglie, 金谷钱, Arjen B. Blom, Desirée L. Bos, Thomas Vogl, Sander W. Tas, Trine Julie Abrahamsen, Mats Bergström, D.M. Thornton, P.M. van der Kraan, Peter Laverman, Marije I. Koenders, P.L. van Lent, Martijn H. J. van den Bosch	2023	5
2	Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand European Journal of Nuclear Medicine and Molecular Imaging ·Yvonne H. W. Derks, Melline G.M. Schilham, Mark Rijpkema, E. Smeets, Maedeh Bahmani, Annemarie Kip, Sanne A. M. van Lith, Magda Shoukry Hussein, J.P. Michiel Sedelaar, Diederik M. Somford, Michiel Simons, Peter Laverman, Martin Gotthardt, Dennis W. P. M. Löwik, Sandra Heskamp, Susanne Lütje	2023	11
3	Strain-Promoted Azide–Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate Cancer Bioconjugate Chemistry ·Yvonne H. W. Derks, Mark Rijpkema, Maedeh Bahmani, Judith Mara Kish, Rehlish Faraz, Annemarie Kip, Peter Laverman, Susanne Lütje, Sandra Heskamp, Dennis W. P. M. Löwik	2021	19
4	New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals European Journal of Nuclear Medicine and Molecular Imaging ·Inês F. Antunes, Gerben M. Franssen, Mercedes Fabiola Moreno Benitez, Peter Laverman, Hendrikus H. Boersma, 李垠澈	2020	3
5	A Fully Automated Procedure for the GMP-Synthesis of 68Ga-NODAGA-Exendin-4 Using a Cationic Purification Method European Journal of Nuclear Medicine and Molecular Imaging ·Gerben M. Franssen, Maarten Brom, 情報・図書館チーム利用者サービス担当, Peter Laverman, Xiangbo Zeng, Martin Gotthardt, Otto C. Boerman	2015	2
6	[ 18 ]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis Journal of Controlled Release ·Bart-Jan Sweers, Josbert M. Metselaar, Danny Gerrits, P.L. van Lent, Gert Storm, Peter Laverman, Otto C. Boerman	2015	21
7	Comparison of three remote radiolabelling methods for long-circulating liposomes Journal of Controlled Release ·Bart-Jan Sweers, Peter Laverman, Danny Gerrits, Gerben M. Franssen, Josbert M. Metselaar, Gert Storm, Otto C. Boerman	2015	23
8	Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity Pharmaceutical Research ·M. Luísa Corvo, H. Susana Marinho, Paulo Marcelino, Rui M. Lopes, Carlos Vale, 恭久千葉, Hyun Jin Han, Peter Laverman, Gert Storm, M.B.F. Martins	2014	30
9	Preclinical Comparison of Al¹⁸F- and ⁶⁸Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer Journal of Nuclear Medicine ·Kristell L.S. Chatalic, Gerben M. Franssen, Wytske M. van Weerden, William J. McBride, Peter Laverman, Shi Qi Lim, 重孝志村, Luc Brunel, David M. Goldenberg, Jean‐Alain Fehrentz, Jean Martínez, Otto C. Boerman, Marion de Jong	2014	44
10	ImmunoPET Imaging of Renal Cell Carcinoma with ¹²⁴ I- and ⁸⁹ Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice Cancer Biotherapy and Radiopharmaceuticals ·Alexander B. Stillebroer, Gerben M. Franssen, Peter F.A. Mulders, Wim J.G. Oyen, Guus A.M.S. van Dongen, Peter Laverman, Egbert Oosterwijk, Otto C. Boerman	2013	42
11	Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images EJNMMI Research ·Adnan Nur Hanafi, A. S. Kochhar, Peter Laverman, Otto C. Boerman, Freek J. Beekman	2013	4
12	Dual Contrast Agent for Computed Tomography and Magnetic Resonance Hard Tissue Imaging Tissue Engineering Part C Methods ·Manuela Ventura, Yi Sun, 正春永嶋, Peter Laverman, Paul Borm, Arend Heerschap, Egbert Oosterwijk, Otto C. Boerman, John A. Jansen, X. Frank Walboomers	2012	20
13	Optimized labeling of NOTA-conjugated octreotide with F-18 Tumor Biology ·Peter Laverman, Christopher D'Souza, Annemarie Eek, William J. McBride, Robert M. Sharkey, Wim J.G. Oyen, David M. Goldenberg, Otto C. Boerman	2011	65
14	Quantitative multi-pinhole small-animal SPECT: uniform versus non-uniform Chang attenuation correction Physics in Medicine and Biology ·Adnan Nur Hanafi, Johan R. de Jong, A. S. Kochhar, Frans van der Have, Brendan Vastenhouw, Peter Laverman, Otto C. Boerman, R. A. Dierckx, Freek J. Beekman	2011	26
15	No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation The Journal of Immunology ·Paul J. Tacken, Ben Joosten, Anita Reddy, Dayang Wu, Annemarie Eek, Peter Laverman, Anke Kretz-Rommel, Gosse J. Adema, Ruurd Torensma, Carl G. Figdor	2008	34
16	PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation Nuclear Medicine and Biology ·Huub J J M Rennen, Peter Laverman, Julliëtte E M van Eerd, Wim J.G. Oyen, Frans H.M. Corstens, Otto C. Boerman	2007	16
17	Fluorinated amino acids for tumour imaging with positron emission tomography European Journal of Nuclear Medicine and Molecular Imaging ·Peter Laverman, Otto C. Boerman, Frans H.M. Corstens, Wim J.G. Oyen	2002	158
18	Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity Implications in experimental and clinical oncology Biochimica et Biophysica Acta (BBA) - General Subjects ·Peter Laverman	2001	25
19	Preclinical and Clinical Evidence for Efficient Opsonization of Poly(Ethyleneglycol)-Liposomes Journal of Liposome Research ·G. Storm, Peter Laverman, E.T.M. Dams, Christien Oussoren, Frans H.M. Corstens, Wim J.G. Oyen, Otto C. Boerman	2000	1
20	Detection of infection and inflammation with technetium-99m-labeled PEG-liposomes European Journal of Nuclear Medicine and Molecular Imaging ·E.T.M. Dams, Wim J.G. Oyen, O.C. Boerman, Peter Laverman, G. Storm, Jeroen Bakker, J.W.M. van der Meer, Frans H.M. Corstens	1999	1

About Peter Laverman

Peter Laverman is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biomaterials, Immunology and Allergy and Pharmaceutical Science, having authored 123 papers that have together received 5.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (48 papers), Peptidase Inhibition and Analysis (27 papers), Medical Imaging Techniques and Applications (24 papers), Nanoparticle-Based Drug Delivery (17 papers), Neuroendocrine Tumor Research Advances (17 papers), Orthopedic Infections and Treatments (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Neuropeptides and Animal Physiology (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.3k citations), Biomaterials (1.1k citations), Pharmaceutical Science (395 citations), Oncology (1.3k citations) and Immunology and Allergy (156 citations). Peter Laverman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Otto C. Boerman, Wim J.G. Oyen, Frans H.M. Corstens, Gert Storm, E.T.M. Dams, David M. Goldenberg, William J. McBride, Robert M. Sharkey, Gerben M. Franssen and J.W.M. van der Meer. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Bioconjugate Chemistry, Nuclear Medicine and Biology and Molecular Imaging and Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact